通策医疗（600763）8月7日主力资金净流入3471.39万元

Group 1 - The core viewpoint of the news is that Tongce Medical (600763) has shown a stable performance in terms of stock price and financial results, indicating potential investment opportunities [1][3] - As of August 7, 2025, the stock price of Tongce Medical closed at 45.26 yuan, with a slight increase of 0.38% and a trading volume of 10.71 million shares, amounting to 486 million yuan [1] - The net inflow of main funds today was 34.71 million yuan, accounting for 7.14% of the total transaction amount, with significant contributions from large orders [1] Group 2 - For the first quarter of 2025, Tongce Medical reported total operating revenue of 745 million yuan, a year-on-year increase of 5.11%, and a net profit attributable to shareholders of 184 million yuan, up 6.22% year-on-year [1] - The company has a current ratio of 1.605, a quick ratio of 1.556, and a debt-to-asset ratio of 26.97%, indicating a solid financial position [1] - Tongce Medical was established in 1995 and is based in Hangzhou, with a registered capital of approximately 4.47 billion yuan [1][2]